{"Name":"MAP Pharmaceuticals","perma":"map-pharmaceuticals","BasicInfo":{"funded":"2003-01-01","isClosed":false,"closed":null,"short":"MAP Pharmaceuticals is focusedÂ on developing novel inhalation therapies for respiratory and systemic diseases."},"FundingRounds":[{"funding_type":"venture","series":"d","announcedDate":"2007-03-28","moneyRaised":50000000}],"Acquisitions":[],"AcquiredBy":{"price":958000000,"paymentType":"cash","announcedDate":"2013-01-22","completedDate":null,"acquisitionType":"Acquisition","acquirer":"Allergan"},"IPO":{"exchange":"NASDAQ","symbol":"MAPP","shares":5000000,"date":"2007-10-05","openPrice":12,"moneyRaised":60000000,"valuation":null},"Investments":[],"Products":[],"ProductsPermas":[],"CurrentTeam":[{"title":"CEO","started":null,"ended":null,"firstName":null,"lastName":null}],"PastTeam":[{"title":"Director of Regulatory Affairs","started":null,"ended":null,"firstName":"Mahtab","lastName":"Fatemi"},{"title":"Senior Vice President and Chief Financial Officer","started":null,"ended":null,"firstName":"Christopher Y.","lastName":"Chai"}]}
